Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China

Chronic lymphocytic leukemia (CLL) is characterized by high heterogeneity in clinical features and outcomes in Western countries and China. In this study, the clinical and laboratory data of 210 CLL patients who were admitted to a single center in China between 2002 and 2011 were retrospectively ana...

Descripción completa

Detalles Bibliográficos
Autores principales: XU, ZHENSHU, ZHANG, JINYAN, WU, SHUNQUAN, ZHENG, ZHIHONG, CHEN, ZHIZHE, ZHAN, RONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629227/
https://www.ncbi.nlm.nih.gov/pubmed/23599777
http://dx.doi.org/10.3892/ol.2013.1177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629227/
https://www.ncbi.nlm.nih.gov/pubmed/23599777
http://dx.doi.org/10.3892/ol.2013.1177

Ejemplares similares